Skip to main content

New way to detox? ‘Gold of Pleasure’ oilseed boosts liver detoxification enzymes  

University of Illinois scientists have found compounds that boost liver detoxification enzymes nearly fivefold, and they’ve found them in a pretty unlikely place—the crushed seeds left after oil extraction from an oilseed crop used in jet fuel.

“The bioactive compounds in Camelina sativa seed, also known as Gold of Pleasure, are a mixture of phytochemicals that work together synergistically far better than they do alone. The seed meal is a promising nutritional supplement because its bioactive ingredients increase the liver’s ability to clear foreign chemicals and oxidative products. And that gives it potential anti-cancer benefit,” said Elizabeth Jeffery, a U of I professor of nutritional toxicology.

Oilseed crops, including rapeseed, canola, and camelina, contain some of the same bioactive ingredients—namely, glucosinolates and flavonoids—found in broccoli and other cruciferous vegetables and in nearly the same quantities, she noted.

Because the oil from oilseed crops makes an environmentally friendly biofuel, scientists have been hoping to find a green use for the protein-rich seed meal left after oil extraction. Animal feed was the obvious choice, but there were a couple of problems. Some rapeseed glucosinolates are toxic, and producers have balked at paying Canada for canola seed, the low-glucosinolate rapeseed that country had developed.

Jeffery thought Camelina sativa was worth a look so she began to work with USDA scientist Mark Berhow. In the first study of camelina’s bioactive properties, Berhow isolated four major components—three glucosinolates and the flavonoid quercetin—from its defatted seed meal.

Back at Jeffery’s U of I lab, researchers began to test these components on mouse liver cells both individually and together. They found that all four major camelina bioactives induced the detoxifying liver enzyme NQO1 when they were used alone. However, when a particular glucosinolate, GSL9, was paired with the flavonoid quercetin, there was a synergistic effect.

“When these two bioactives were combined, induction of the detoxifying liver enzyme increased nearly fivefold,” said Nilanjan Das, a postdoctoral student in Jeffery’s lab.

In all the experiments, the scientists used sulforaphane, the cancer-protective component of broccoli, as a control because it is known to induce NQO1, the detoxifying enzyme. Like camelina seed meal, broccoli contains the flavonoid quercetin, so they decided to look for synergy between sulforaphane and quercetin.

“As had been the case with camelina’s GSL9 and quercetin, the combined effect of quercetin and sulforaphane—in proportions found naturally in broccoli—was far greater than when either was used alone. This demonstrates to us the importance of eating whole foods. Thanks to synergy among its bioactive components, whole broccoli appears to be more powerful than purified sulforaphane that you might buy at a vitamin store or on the Internet,” Das said.


Nilanjan Das, Mark A. Berhow, Donato Angelina, and Elizabeth H. Jeffery are co-authors of “Camelina sativa Defatted Seed Meal Contains Both Alkyl Sulfinyl Glucosinolates and Quertecin that Synergize Bioactivity.” The article is available pre-publication online in the Journal of Agricultural and Food Chemistry. Funding was provided by USDA.  SOURCE:SCIENCE BLOG

Comments

Popular posts from this blog

VIDEO AND PICTURES: BOWEN UNIVERSITY HOSTEL BURNT

                    A room (precisely Luke Hostel room 47) got burnt in the early hours of Thursday March 27 2015. Most of the room's occupants' luggage were burnt, including books, clothes, boxes and several valuable items. Some people are speculating that the fire was caused by a boiling ring left on by one of the students while others are saying that it was caused by an unplugged iron. Thankfully no lives were lost and nobody was wounded.                     Minutes after the fire was doused, the Dean of Student affairs, MRS. Sangoyomi was seen in the hostel examining the room. The fate of the room's occupants are not yet known but we hope they don't get into much trouble. Come back for updates on this post and more info.PICTURES BELOW

The genetic and scientific view of the EBOLA VIRUS

Virology The EBOV genome is approximately 19 kb in length. It encodes seven structural proteins: nucleoprotein (NP), polymerase cofactor (VP35), (VP40), GP, transcription activator (VP30), VP24, and RNA polymerase (L).[3] Structure[edit] Electron micrographs of EBOV show them to have the characteristic threadlike structure of a filovirus.[4] EBOV VP30 is around 288 amino acids long.[5] The virions are tubular in general form but variable in overall shape and may appear as the classic shepherd's crook or eyebolt, as a U or a 6, or coiled, circular, or branched; laboratory techniques, such as centrifugation, may be the origin of some of these formations.[6] Virions are generally 80 nm in diameter with a lipid bilayer anchoring the glycoprotein which projects 7 to 10 nm long spikes from its surface.[7] They are of variable length, typically around 800 nm, but may be up to 1000 nm long. In the center of the virion is a structure called nucleocapsid, which is formed by the helically wou...

U.S. Missionary who contacted Ebola virus flown out of Liberia.

A second U.S. missionary who contracted Ebola in Liberia has arrived back in the United States. Nancy Writebol traveled on a specially outfitted plane that landed in the southeastern city of Atlanta on Tuesday. She will be treated at Emory University Hospital, alongside an American doctor who also contracted the deadly virus while treating patients in Liberia. Both received a dose of an experimental serum before leaving Liberia. On Monday, officials at a New York City hospital said a man suffering from a high fever and gastrointestinal problems arrived at the emergency room and was quickly isolated. They say the patient recently traveled to a West African country where Ebola has been reported, and is now undergoing tests to determine the cause of his illness. No other details about the man were given. Authorities in Nigeria Monday reported the country's second confirmed case of Ebola -- a doctor who treated the first patient who died July 25 in Lagos. Eight others are being monitor...